Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Investigation of Efficacy and Safety of Insulin Glargine Versus Metformin as First Line Drug in Treatment of Early Type 2 Diabetes

NCT00857870 is registered in ClinicalTrials.gov with GWT-TUD GmbH as lead sponsor.

NCT NCT00857870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00857870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Investigation of Efficacy and Safety of Insulin Glargine Versus Metformin as First Line Drug in Treatment of Early Type 2 Diabetes
Lead sponsor
GWT-TUD GmbH
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2009
Completion date
December 31, 2011
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes